TrialEuropean urology focus2021

Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome.

Jeremie Calais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.